Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

NCT00001445 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

BIOLOGICAL: HIV-1 Immunogen

Sponsor

National Cancer Institute (NCI)